| ICG00153-110 |
| ICG00153-105 |
| Gene Symbol | Gene Model | Application Scenario | Accession Number | Primers(5' - 3') (Forward/Reverse) |
Size (bp) | Annealing Temperature | Detection |
|---|---|---|---|---|---|---|---|
| CypA | Cytochrome |
Disease Severity
SARS-CoV-2 Infection
COVID-19
|
NM_021130 |
F: GTCAACCCCACCGTGTTCTTC
R: TTTCTGCTGTCTTTGGGACCTTG
|
- | 60 | SYBR |
| TBP | TATA-binding Protein |
Disease Severity
SARS-CoV-2 Infection
COVID-19
|
NM_003194 |
F: CAGTGACCCAGCAGCATCACT
R: AGGCCAAGCCCTGAGCGTAA
|
- | 60 | SYBR |
mRNA
| Gene Symbol | Gene Model | Application Scenario | Accession Number | Primers(5' - 3') (Forward/Reverse) |
Size (bp) | Annealing Temperature | Detection |
|---|---|---|---|---|---|---|---|
| miR-186-5p | MiRNA |
Peripheral Blood
SARS-CoV-2 Infection
COVID-19
|
- |
F: Please contact with the researchers for details.
R: Please contact with the researchers for details.
|
- | - | TaqMan |
| miR-186-5p | MiRNA |
Peripheral Blood
SARS-CoV-2 Infection
COVID-19
|
- |
F: Please contact with the researchers for details.
R: Please contact with the researchers for details.
|
- | - | TaqMan |